Partner pricing versus pass-through, plainly
VSDH's model combines wholesale catalog pricing to partners with clinic-facing economics that often include revenue share and custom quotes rather than public per-vial rates on vsdigitalhealth.com. Its public FAQ directs clinics to request a custom quote as of June 2026. That can produce competitive rates at volume inside a white-label or ConnectRxCare relationship — a real strength when launching a D2C brand. The cost is visibility: landed per-vial cost may not appear at the moment you quote a semaglutide or tirzepatide patient, and separating drug cost from platform margin requires reading partner agreements rather than reading a cart line.
Pass-through pricing inverts that for clinic ops. With Fizy Health, resolved 503A landed cost appears on each catalog and cart line before checkout, and the platform's margin is a disclosed facilitation fee at payment — not an opaque layer inside the vial cost or a revenue-share stack. For a clinic quoting cash-pay patients daily, the price you quote and the price you pay trace to the same visible number. VSDH-as-supplier and VSDH-as-platform remain distinct: you may keep overlapping fulfillment while replacing how pricing surfaces to your team.